Stay updated on Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Sign up to get notified when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.
Latest updates to the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference4%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedNew features have been added to the website, while several options related to intervention/treatment downloads and data field selections have been removed.SummaryDifference6%
- Check35 days agoChange DetectedSeveral key health-related links have been removed, including those related to genetic conditions like Leber congenital amaurosis and retinitis pigmentosa, as well as resources from MedlinePlus and NIH.SummaryDifference1%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new links added related to genetics, rare diseases, and medical interventions, while the previous version 2.12.1 has been removed.SummaryDifference7%
- Check50 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.